Get started
Author

Antonios Psarras

Observed names: A Psarras, A. Psarras, Anthony Psarras, Psarras, Antonios
Observed institutions: University of Pisa, University of Leeds, Beth Israel Deaconess Medical Center, Harvard University, Aristotle University of Thessaloniki, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, Nuffield Orthopaedic Centre, Herlev Hospital, Glostrup Hospital, Rigshospitalet, John Radcliffe Hospital, National Institute for Health and Care Research, University of Oxford, NIHR Leeds Musculoskeletal Biomedical Research Unit, Ippokrateio General Hospital of Thessaloniki, Oxford University Hospitals NHS Trust, Kennedy Institute of Rheumatology, University of Pennsylvania
ORCID: 0000-0002-6318-0171
Observed ORCID: 0000-0002-6318-0171
OpenAlex ID: A5043900874
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity
2020 · Antonios Psarras, Adewonuola Alase, et al. · Nature Communications · 185
PDF
Type I interferon–mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy
2016 · Antonios Psarras, Paul Emery, et al. · Rheumatology · 178
Emerging concepts of type I interferons in SLE pathogenesis and therapy
2022 · Antonios Psarras, Miriam Wittmann, et al. · Nature Reviews Rheumatology · 160
Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status
2018 · Md Yuzaiful Md Yusof, Antonios Psarras, et al. · Annals of the Rheumatic Diseases · 118
PDF
A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features
2018 · Y. M. El-Sherbiny, A. Psarras, et al. · Scientific Reports · 92
PDF
TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-α Production and Enhancing T Cell Activation
2021 · Antonios Psarras, Agne Antanaviciute, et al. · The Journal of Immunology · 88
PDF
A critical view on cardiovascular risk in systemic sclerosis
2016 · Antonios Psarras, Stergios Soulaidopoulos, et al. · Rheumatology International · 53
A cellular overview of immunometabolism in systemic lupus erythematosus
2023 · Antonios Psarras, Alexander Clarke · Oxford Open Immunology · 30
PDF
B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus
2019 · Yasser M. El‐Sherbiny, Md Yuzaiful Md Yusof, et al. · Arthritis & Rheumatology · 30
PDF
Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus
2022 · Lucy M. Carter, Adewonuola Alase, et al. · Arthritis & Rheumatology · 18
PDF
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope
2023 · Md Yuzaiful Md Yusof, Eve M D Smith, et al. · Rheumatology Advances in Practice · 16
PDF
Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology
2024 · Lucy Marie Carter, Md Yuzaiful Md Yusof, et al. · Annals of the Rheumatic Diseases · 13
PDF
Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features
2018 · Y. M. El-Sherbiny, A. Psarras, et al. · Scientific Reports · 12
PDF
The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus
2026 · Md Yuzaiful Md Yusof, Eve M D Smith, et al. · Rheumatology · 11
Systemic Sclerosis and Silicone Breast Implant: A Case Report and Review of the Literature
2014 · Antonios Psarras, Ioannis Gkougkourelas, et al. · Case Reports in Rheumatology · 7
PDF
A9.05 Distinct subsets of interferon-stimulated genes are associated with incomplete and established systemic lupus erythematosus
2016 · A Psarras, MY Md Yusof, et al. · Annals of the Rheumatic Diseases · 6
Keratinocytes: From passive targets to active mediators of systemic autoimmunity
2022 · Antonios Psarras, Edward M. Vital · Science Translational Medicine · 5
Ab0115 Cd14+ Myeloid Cells Express the Pdc Markers Bdca-2, Bdca-4, Cd123 Upon Differentiation in Both Healthy Individuals and Sle Patients
2023 · A. Psarras, Z. Wigston, et al. · Annals of the Rheumatic Diseases · 4
PDF
Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus
2022 · Antonios Psarras, Edward M Vital · New England Journal of Medicine · 3
71 Prediction of response to rituximab in SLE using a validated two-score system for interferon status
2019 · Adewonuola Alase, Zoe Wigston, et al. · Lupus Science & Medicine · 2
PDF
Systemic Lupus Erythematosus With Cardiac Tamponade and Myocardial Edema in the Early Postpartum Period
2025 · Asad Shabbir, Fatima A.M. Abdulsalam, et al. · JACC Case Reports · 1
Editorial: New insights into interferons and proinflammatory cytokines in lupus
2024 · Wendy I. White, Jillian M. Richmond, et al. · Frontiers in Lupus · 1
PDF
P24 Differentiated monocytes express the pDC markers BDCA-2 and CD123
2024 · Antonios Psarras, Zoe Wigston, et al. · Lupus Science & Medicine · 1
PDF
Pos1450 3-year Analyses of At-risk Ana-positive Cohort: Prognostic Value of Clinical and Interferon Biomarkers Towards Autoimmunity
2023 · M.Y. MD Yusof, S.U. Hassan, et al. · Annals of the Rheumatic Diseases · 1
PDF
Op0134 Novel Interferon Gene Expression Scores Predict Refractory Severe Cutaneous Disease Following Rituximab Therapy in Sle
2021 · L.M. Carter, A. Alase, et al. · Annals of the Rheumatic Diseases · 1
PDF
Works count: 55
Citation count: 1,039
H-index: 12
I10-index: 14
Year
Topic
Type